๐ฐ Immunic Inc News
Page 2 - Immunic Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Immunic Inc. Real-time updates on events, politics, business and more.
March 24, 2024
Sweet Financial Partners LLC purchased a new stake in Immunic, Inc. (NASDAQ:IMUX – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 29,829 shares of the company’s stock, valued at approximately $45,000. Sweet Financial Partners LLC owned 0.07% of Immunic at the […]
February 29, 2024
Immunic Inc (NASDAQ:IMUX) announced that it will present data from its Phase 2 CALLIPER and CALVID-1 clinical trials of its lead asset vidofludimus calcium...
February 29, 2024
The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
February 23, 2024
Immunic, Inc. beats earnings expectations. Reported EPS is $-0.48, expectations were $-0.51.
February 22, 2024
โ Significantly Strengthened Balance Sheet in January 2024 with Execution of Three-Tranche Private Placement of up to $240 Million, Extending Cash Runway Into the Third Quarter of 2025 Based on...
February 22, 2024
Biotech Stock News Bite - Immunic, Inc. (Nasdaq: IMUX) Year End 2023 Financial Results and Provides Corporate Update
February 16, 2024
Immunic (NASDAQ:IMUX – Get Free Report) will be announcing its earnings results before the market opens on Thursday, February 22nd. Analysts expect the company to announce earnings of ($0.51) per share for the quarter. Immunic (NASDAQ:IMUX – Get Free Report) last released its earnings results on Tuesday, November 14th. The company reported ($0.51) EPS for […]
February 7, 2024
Immunic, Inc. (NASDAQ:IMUX – Free Report) – Analysts at Leerink Partnrs issued their FY2028 earnings per share estimates for shares of Immunic in a research report issued to clients and investors on Monday, February 5th. Leerink Partnrs analyst T. Smith expects that the company will earn ($0.66) per share for the year. The consensus estimate […]
February 1, 2024
NEW YORK, Feb. 1, 2024 /PRNewswire/ --ย Immunic, Inc.ย ,ย a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and...
January 29, 2024
Immunic, Inc. (NASDAQ:IMUX – Get Free Report) saw a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 3,260,000 shares, an increase of 48.2% from the December 31st total of 2,200,000 shares. Based on an average daily volume of 768,700 shares, the days-to-cover ratio is […]